108 related articles for article (PubMed ID: 32301486)
1. TNFα signalling predicts poor prognosis of patients with endometrial cancer.
Wieser V; Abdel Azim S; Sprung S; Knoll K; Kögl J; Hackl H; Marth C; Zeimet AG; Fiegl H
Carcinogenesis; 2020 Aug; 41(8):1065-1073. PubMed ID: 32301486
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor receptor modulator spermatogenesis-associated protein 2 is a novel predictor of outcome in ovarian cancer.
Wieser V; Tsibulak I; Degasper C; Welponer H; Leitner K; Parson W; Zeimet AG; Marth C; Fiegl H
Cancer Sci; 2019 Mar; 110(3):1117-1126. PubMed ID: 30697874
[TBL] [Abstract][Full Text] [Related]
3. SPATA2 links CYLD to the TNF-α receptor signaling complex and modulates the receptor signaling outcomes.
Wagner SA; Satpathy S; Beli P; Choudhary C
EMBO J; 2016 Sep; 35(17):1868-84. PubMed ID: 27307491
[TBL] [Abstract][Full Text] [Related]
4. Decreased expression of TFAP2B in endometrial cancer predicts poor prognosis: A study based on TCGA data.
Wu H; Zhang J
Gynecol Oncol; 2018 Jun; 149(3):592-597. PubMed ID: 29602546
[TBL] [Abstract][Full Text] [Related]
5. SPATA2 promotes CYLD activity and regulates TNF-induced NF-κB signaling and cell death.
Schlicher L; Wissler M; Preiss F; Brauns-Schubert P; Jakob C; Dumit V; Borner C; Dengjel J; Maurer U
EMBO Rep; 2016 Oct; 17(10):1485-1497. PubMed ID: 27458237
[TBL] [Abstract][Full Text] [Related]
6. The role of SPATA2 in TNF signaling, cancer, and spermatogenesis.
Masola V; Greco N; Tozzo P; Caenazzo L; Onisto M
Cell Death Dis; 2022 Nov; 13(11):977. PubMed ID: 36402749
[TBL] [Abstract][Full Text] [Related]
7. L1CAM is an independent predictor of poor survival in endometrial cancer - An analysis of The Cancer Genome Atlas (TCGA).
Dellinger TH; Smith DD; Ouyang C; Warden CD; Williams JC; Han ES
Gynecol Oncol; 2016 May; 141(2):336-340. PubMed ID: 26861585
[TBL] [Abstract][Full Text] [Related]
8. SPATA2: more than a missing link.
Schlicher L; Brauns-Schubert P; Schubert F; Maurer U
Cell Death Differ; 2017 Jul; 24(7):1142-1147. PubMed ID: 28282038
[TBL] [Abstract][Full Text] [Related]
9. SPATA2 regulates the activation of RIPK1 by modulating linear ubiquitination.
Wei R; Xu LW; Liu J; Li Y; Zhang P; Shan B; Lu X; Qian L; Wu Z; Dong K; Zhu H; Pan L; Yuan J; Pan H
Genes Dev; 2017 Jun; 31(11):1162-1176. PubMed ID: 28701375
[TBL] [Abstract][Full Text] [Related]
10. High TRIM44 expression in endometrial carcinoma is associated with a poorer patient outcome.
Li P; Yin H; Meng F; Liu S; Liu H; Ma R
Pathol Res Pract; 2018 May; 214(5):727-731. PubMed ID: 29526558
[TBL] [Abstract][Full Text] [Related]
11. Identification of a metabolism-related gene expression prognostic model in endometrial carcinoma patients.
Jiang P; Sun W; Shen N; Huang X; Fu S
BMC Cancer; 2020 Sep; 20(1):864. PubMed ID: 32894095
[TBL] [Abstract][Full Text] [Related]
12. MELK promotes Endometrial carcinoma progression via activating mTOR signaling pathway.
Xu Q; Ge Q; Zhou Y; Yang B; Yang Q; Jiang S; Jiang R; Ai Z; Zhang Z; Teng Y
EBioMedicine; 2020 Jan; 51():102609. PubMed ID: 31915116
[TBL] [Abstract][Full Text] [Related]
13. Expression of DNA repair proteins in endometrial cancer predicts disease outcome.
Mhawech-Fauceglia P; Wang D; Kim G; Sharifian M; Chen X; Liu Q; Lin YG; Liu S; Pejovic T
Gynecol Oncol; 2014 Mar; 132(3):593-8. PubMed ID: 24508840
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of genes involved in the insulin signalling pathway (IGF1, PTEN and IGFBP1) in the endometrium may link polycystic ovarian syndrome and endometrial cancer.
Shafiee MN; Seedhouse C; Mongan N; Chapman C; Deen S; Abu J; Atiomo W
Mol Cell Endocrinol; 2016 Mar; 424():94-101. PubMed ID: 26802879
[TBL] [Abstract][Full Text] [Related]
15. Glasgow prognostic score is a prognosis predictor for patients with endometrial cancer.
Saijo M; Nakamura K; Masuyama H; Ida N; Haruma T; Kusumoto T; Seki N; Hiramatsu Y
Eur J Obstet Gynecol Reprod Biol; 2017 Mar; 210():355-359. PubMed ID: 28129563
[TBL] [Abstract][Full Text] [Related]
16. The long non-coding RNA HOTAIR is upregulated in endometrial carcinoma and correlates with poor prognosis.
He X; Bao W; Li X; Chen Z; Che Q; Wang H; Wan XP
Int J Mol Med; 2014 Feb; 33(2):325-32. PubMed ID: 24285342
[TBL] [Abstract][Full Text] [Related]
17. Tumour heterogeneity revealed by unsupervised decomposition of dynamic contrast-enhanced magnetic resonance imaging is associated with underlying gene expression patterns and poor survival in breast cancer patients.
Fan M; Xia P; Liu B; Zhang L; Wang Y; Gao X; Li L
Breast Cancer Res; 2019 Oct; 21(1):112. PubMed ID: 31623683
[TBL] [Abstract][Full Text] [Related]
18. The Impact of Androgen Receptor Expression on Endometrial Carcinoma Recurrence and Survival.
Mahdi Z; Abdulfatah E; Pardeshi V; Hassan O; Schultz D; Morris R; Cote ML; Elshaikh MA; Bandyopadhyay S; Ali-Fehmi R
Int J Gynecol Pathol; 2017 Sep; 36(5):405-411. PubMed ID: 28277313
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization and expression profiling of 17-beta-hydroxysteroid dehydrogenase 2 and spermatogenesis associated protein 2 genes in endangered catfish,
Agarwal D; Gireesh-Babu P; Pavan-Kumar A; Koringa P; Joshi CG; Gora A; Bhat IA; Chaudhari A
Anim Biotechnol; 2020 Apr; 31(2):93-106. PubMed ID: 30570357
[TBL] [Abstract][Full Text] [Related]
20. Contribution of cervical cytology in the diagnostic work-up of patients with endometrial cancer.
Amkreutz LCM; Pijnenborg JMA; Joosten DWL; Mertens HJMM; Van Kuijk SMJ; Engelen MJA; Bergmans M; Nolting WE; Kruitwagen RFPM
Cytopathology; 2018 Feb; 29(1):63-70. PubMed ID: 29280216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
